Illingworth v. Evergreen Medicinal Supply Inc., 2018 BCCA 444

JurisdictionBritish Columbia
JudgeD. Smith,Willcock,Fenlon
Citation2018 BCCA 444
Date27 November 2018
CourtCourt of Appeal (British Columbia)
Docket NumberCA44982
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
5 practice notes
  • Khela v. Clarke,
    • Canada
    • Supreme Court of British Columbia (Canada)
    • 19 Marzo 2021
    ...doctrine operates in the context of an existing legal relationship between the parties: Illingworth v. Evergreen Medicinal Supply Inc., 2018 BCCA 444 [Illingworth]; Ecobase Enterprises Inc. v. Mass Enterprise Inc., 2017 BCCA 29 [Ecobase]; Remington Energy Ltd. v. British Columbia Hydro &......
  • Illingworth v. Evergreen Medicinal Supply Inc., 2019 BCCA 471
    • Canada
    • Court of Appeal (British Columbia)
    • 23 Diciembre 2019
    ...of his petition. This Court released its decision on November 27, 2018, reported at Illingworth v. Evergreen Medicinal Supply Inc., 2018 BCCA 444 [“Illingworth [41] On the appeal, Mr. Illingworth denied an oral agreement with Evergreen that he was responsible for all construction costs. Eve......
  • DOLTER v. INPUT CAPITAL CORPORATION,
    • Canada
    • Court of Queen's Bench of Saskatchewan (Canada)
    • 1 Enero 2022
    ...[1991] 2 SCR 50 [Maracle] which dealt with promissory estoppel. The Court of Appeal in Illingworth v Evergreen Medicinal Supply Inc., 2018 BCCA 444 neatly summarized the test [51] The legal test for promissory estoppel was set out in Maracle v. Travelers Indemnity Co. of Canada, [1991] 2 S.......
  • Wutif Capital (VCC) Inc. v. Mazza Innovation Ltd., 2019 BCSC 1245
    • Canada
    • Supreme Court of British Columbia (Canada)
    • 4 Julio 2019
    ...the promisor to insist on their strict legal rights between the parties would be unfair. (Illingworth v. Evergreen Medicinal Supply Inc., 2018 BCCA 444 at paras. [48] The respondents say that in late 2017 or early 2018, Mr. Volker, the principal of Wutif, had discussions with management of ......
  • Request a trial to view additional results
5 cases
  • Khela v. Clarke,
    • Canada
    • Supreme Court of British Columbia (Canada)
    • 19 Marzo 2021
    ...doctrine operates in the context of an existing legal relationship between the parties: Illingworth v. Evergreen Medicinal Supply Inc., 2018 BCCA 444 [Illingworth]; Ecobase Enterprises Inc. v. Mass Enterprise Inc., 2017 BCCA 29 [Ecobase]; Remington Energy Ltd. v. British Columbia Hydro &......
  • Illingworth v. Evergreen Medicinal Supply Inc., 2019 BCCA 471
    • Canada
    • Court of Appeal (British Columbia)
    • 23 Diciembre 2019
    ...of his petition. This Court released its decision on November 27, 2018, reported at Illingworth v. Evergreen Medicinal Supply Inc., 2018 BCCA 444 [“Illingworth [41] On the appeal, Mr. Illingworth denied an oral agreement with Evergreen that he was responsible for all construction costs. Eve......
  • DOLTER v. INPUT CAPITAL CORPORATION,
    • Canada
    • Court of Queen's Bench of Saskatchewan (Canada)
    • 1 Enero 2022
    ...[1991] 2 SCR 50 [Maracle] which dealt with promissory estoppel. The Court of Appeal in Illingworth v Evergreen Medicinal Supply Inc., 2018 BCCA 444 neatly summarized the test [51] The legal test for promissory estoppel was set out in Maracle v. Travelers Indemnity Co. of Canada, [1991] 2 S.......
  • Wutif Capital (VCC) Inc. v. Mazza Innovation Ltd., 2019 BCSC 1245
    • Canada
    • Supreme Court of British Columbia (Canada)
    • 4 Julio 2019
    ...the promisor to insist on their strict legal rights between the parties would be unfair. (Illingworth v. Evergreen Medicinal Supply Inc., 2018 BCCA 444 at paras. [48] The respondents say that in late 2017 or early 2018, Mr. Volker, the principal of Wutif, had discussions with management of ......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT